For investors

PolTiss gives opportunity to take part in development of technology, which will be the new standard in soft tissue reconstruction and will substitute current imperfect solutions.

PhotoBioCure™ applies to most common surgical operations in the world and we talk about several billion dollars market.

Being in Poland PolTiss has access to the best research staff, the finest lab space and very attractive granting programmes.

Investing in PolTiss gives very clear exit opportunity for investors.
PhotoBioCure™ technology is already patented in US and Poland (European procedure is in progress) and PolTiss holds very attractive licenses for that.

However our main advantage is our team with unique composition of research&development experience with business competences.

We are passionate and determined to develop the company, build its value and deliver returns for our investors.

Contact us to discuss an investment!

PolTiss Team

    Want to know more?

    If you are interested in our services, if you want to know more, if you have a question, comment or just want to write to us – please fill in the form below. We will contact you as soon as possible.